Dubai-UAE: 22. July, 2009 – NewBridge announces that is has entered into an exclusive license and supply agreement with Axcan Pharma for Pylera®, an innovative 3-in-1 capsule therapy for the eradication of Helicobacter pylori, a bacterium now recognized as being the main cause of gastric and duodenal ulcers.
Media
|
Showing Articles Tagged : Africa
NewBridge's Sancuso gets featured in Time Magazine. |